Latest Market News

ACDC Metals is progressing hydrometallurgical testwork on its Goschen Central rare earth project and advancing its White Hills gold exploration licence, aligning with Australia's new $1.2 billion Critical Minerals Strategic Reserve.

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.

Nanoveu Limited has raised A$7.5 million through a strategic placement to accelerate the commercial rollout of its cutting-edge EMASS ECS-DoT semiconductor technology, including a rapid 16nm chip tape-out and live drone validation.

Auris Minerals has secured $3.2 million to expand its geological team and accelerate exploration in Western Australia's Bryah Basin, following mixed assay results from its Morck Well gold prospects.

Blue Star Helium has achieved its first helium production at the Galactica Project, marking a key milestone as it optimizes plant operations and prepares for commercial ramp-up.

Neurizon Therapeutics has secured trademark protection for its NEURIZON® brand across major pharmaceutical markets, reinforcing its intellectual property strategy as it advances its lead drug candidate NUZ-001.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.

Critica Limited has launched a pivotal Scoping Study for its Jupiter Rare Earth Project in Western Australia, appointing Sedgman to define a capital-efficient development pathway. This marks a strategic shift from technical validation to structured economic assessment.

Cazaly Resources has met its initial $1 million farm-in milestone at the Goongarrie Gold Project, earning a 25% interest after identifying continuous gold mineralisation over a 1.3-kilometre strike. The company plans further drilling to expand its stake and explore high-grade targets.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

Cygnus Metals has identified two promising gold prospects within its Chibougamau Project in Quebec, with plans for drilling to expand its resource base and resume work at Golden Eye.